Special Issue "Biobased Nanoscale Drug Delivery Systems"
Deadline for manuscript submissions: 30 November 2021.
Interests: biomaterials; materials engineering; medical textiles; surface functionalization; polymer processing; antimicrobial surfaces biomolecules
Special Issues and Collections in MDPI journals
Special Issue in Processes: Advances of Antimicrobial in Bioengineering
Special Issue in Antibiotics: New Biomolecules and Drug Delivery Systems as Alternatives to Conventional Antibiotics
Special Issue in Polymers: Extraction of Cellulose-Based Polymers from Textile Wastes
Special Issue in Biomolecules: Bio-Based Co-Adjuvant Systems for Infection Control
Special Issue in Nanomaterials: Untargeted versus Targeted Antimicrobial Nanomedicines
Special Issue in International Journal of Molecular Sciences: Biomolecule-Based Biomaterials and Their Application in Drug Delivery Systems
Special Issue in International Journal of Molecular Sciences: Frontiers in Antimicrobial Biomaterials
Nanoparticles or nanocapsules are an attractive tool used in medicine, responsible for several advancements in the diagnosis and treatment of multiple diseases. Between their many applications, their use as drug delivery systems, diagnosis, and the improvement of biocompatible materials properties can be highlighted. Their large functional surface, quantum properties, ability to bind, adsorb, and carry drugs, probes, and proteins are unique features of nanoparticles, which are very important for medical purposes. Even though inorganic systems are the most widely researched, lately, biobased, sustainable solutions have encountered a great demand as they are less harmful not only to the human body but also to the environment. New approaches to deal with the growing concern associated with antibiotic-resistant bacteria and the urgency for target-directed systems that act on a local bases and prevent systemic side effects have boosted research on biobased systems as platforms for drug delivery. This Special Issue seeks manuscript submissions that further our understanding of the ability of organic nanosystems to target and deliver specialized biomolecules in a sustainable way, without causing harmful responses. Further, studies that deal with the advantages of these systems over conventional strategies or inorganic nanoscale approaches are very welcome. Submissions on new processing and extraction methodologies for biobased materials, including biomolecules and polymers, are also encouraged.
Dr. Helena P. Felgueiras
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- organic particles
- biomaterials functionalization
- biological delivery systems
- natural-origin polymers
- organic synthesis
- target-directed platforms
- localized drug action
- antimicrobial agents
- infection control